Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CHTR vs GSK✓SelectedUSD · GSKCHTR vs GSK performance historyLatest closeAs of-4.32%11/19
Stock and ETF performance explorer

CHTR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-67.8%
GSK return
+53.5%
Excess return
-121.3%
Maximum drawdown
-76.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.3%-1.6%-2.8%-3.9%
7D+0.4%-4.7%+5.1%+1.8%
30D+21.0%-4.7%+25.7%+22.6%
3M-12.7%-8.8%-3.9%-10.5%
6M-6.5%-4.6%-1.9%-5.4%
YTD-36.2%+1.0%-37.2%-35.7%
1Y-31.4%+6.9%-38.3%-31.5%
All-67.8%+53.5%-121.3%-71.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling